New Delhi: The U.S. government’s decision to suspend foreign aid disbursements through the United States Agency for International Development (USAID) is expected to have significant repercussions for India’s health and education initiatives. The funding freeze, announced by President Donald Trump, could disrupt ongoing projects aimed at combating tuberculosis (TB), HIV/AIDS, and improving maternal and child healthcare.
Several health programs implemented by organizations like Jhpiego and PATH rely heavily on USAID support. Experts warn that the halt in funding could slow India’s progress in disease prevention and treatment. Similarly, education projects designed to enhance access to quality learning resources in underserved areas may face setbacks.
This move is part of a broader U.S. policy shift affecting global development aid, with implications beyond India. While discussions on possible alternatives continue, stakeholders in India’s public health and education sectors are urging diplomatic engagement to ensure these critical programs remain operational.